PlainRecalls
FDA Drug Moderate Class II Terminated

Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99

Reported: December 25, 2019 Initiated: November 19, 2019 #D-0653-2020

Product Description

Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99

Reason for Recall

Presence of Foreign Tablets/Capsules: One Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..

Details

Recalling Firm
AuroMedics Pharma LLC
Distribution
Nationwide within the United States
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99. Recalled by AuroMedics Pharma LLC.
Why was this product recalled?
Presence of Foreign Tablets/Capsules: One Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..
Which agency issued this recall?
This recall was issued by the FDA Drug on December 25, 2019. Severity: Moderate. Recall number: D-0653-2020.